In a first, 5 Indian pharma majors ally for Covid drug trials

In a first, five Indian pharma majors have joined hands to conduct phase-III clinical trials of investigational anti-viral drug Molnupiravir on mild Covid-19 patients. The companies include Dr Reddy's Laboratories Ltd, Cipla Ltd, Sun Pharmaceutical Industries Ltd, Torrent Pharmaceuticals Ltd and Emcure Pharmaceuticals Ltd. Via Times of India https://ift.tt/2hJjhqE